The ACCP Foundation Ltd Board of Directors will recognize outstanding peer reviewers and authors with awards at the 2025 ACCP Annual Meeting.

ACCP’s 2 official journals engage many peer reviewers who help determine which high-quality articles will be published. These reviewers provide an integral service to the journals by critically evaluating the submitted manuscripts. The best reviewers provide the highest-quality reviews consistently and in a timely manner. The Journal of the American College of Clinical Pharmacy (JACCP) and Pharmacotherapy are pleased to recognize 9 such reviewers:

JACCP Outstanding Reviewers:

• Devin Lavender, Pharm.D., BCPS, BCACP
  University at Georgia College of Pharmacy
• Jody Lounsbery, Pharm.D., BCPS
  University of Minnesota College of Pharmacy
• John Shilka, Pharm.D., BCPS, BCACP
  Retzky College of Pharmacy – University of Illinois Chicago
• Ashley E. Woodruff, Pharm.D., FCCP, BCPS
  University at Buffalo School of Pharmacy and Pharmaceutical Sciences

Pharmacotherapy Outstanding Reviewers:

• Oralia V. Bazaldua, Pharm.D., FCCP, BCACP
  UT Health San Antonio
• Nicholas W. Carris, Pharm.D., MPH, FCCP, BCPS
  University of South Florida
• Christopher Giuliano, Pharm.D., MPH
  Wayne State University Eugene Applebaum College of Pharmacy and Health Sciences/Henry Ford St. John
• N. Jim Rhodes, Pharm.D., MSc, BCPS-AQ Infectious Diseases
  Midwestern University, Chicago College of Pharmacy
• Kristin Watson, Pharm.D., MS, BCCP
  Veterans Affairs Maryland Health Care System

The editors-in-chief and associate and scientific editors of ACCP’s official journals and members of the Foundation’s Board of Directors extend their gratitude to all JACCP and Pharmacotherapy reviewers. Individuals desiring to enroll in the Peer Review Training Program or provide peer review for the ACCP journals can contact Keri Sims ([email protected]).

In addition to the reviewer awards, the Foundation will recognize outstanding authors. The editors-in-chief and associate and scientific editors of ACCP’s official journals and members of the Foundation’s Board of Directors have established the criteria for the Editor’s Choice Awards to recognize outstanding manuscripts published in JACCP and Pharmacotherapy.

Papers are selected by the respective editor-in-chief in collaboration with the supporting editors and board members. Papers selected must have been published in JACCP or Pharmacotherapy within the previous 2 volumes and must be exemplary. Drs C. Lindsay DeVane and Stuart T. Haines are pleased to recognize the following papers.

Editor’s Choice Awards for JACCP

• Ladhar S, Hawkins NM, Virani SA, Turgeon RD. Evaluation of PHARM-HF, a pharmacist-led heart failure medication titration clinic: a pre-post study. J Am Coll Clin Pharm. 2024;7(5):416‐425. https://doi.org/10.1002/jac5.1920
• Smetana KS, Flannery AH, Gurnani PK, et al. PHarmacist avoidance or reductions in medical costs in CRITically ill adults rounding with one SERVICE compared to two or more services: PHARM-CRIT-SERVICE. J Am Coll Clin Pharm. 2023;6(9):1000‐1007. https://doi.org/10.1002/jac5.1798

Editor’s Choice Awards for Pharmacotherapy

• Alhomoud IS, Talasaz A, Mehta A, et al. Role of lipoprotein(a) in atherosclerotic cardiovascular disease: a review of current and emerging therapies. Pharmacotherapy. 2023;43(10):1051-1063. https://doi.org/10.1002/phar.2851
• Stefanos SS, Kiser TH, MacLaren R, Mueller SW, Reynolds PM. Management of noncytotoxic extravasation injuries: a focused update on medications, treatment strategies, and peripheral administration of vasopressors and hypertonic saline. Pharmacotherapy. 2023;43(4):321-337. https://doi.org/10.1002/phar.2794

This year, 3 of the 4 papers recognized for Editor's Choice Awards will also be featured as platform presentations at the Annual Meeting.  Keaton Smetana, Pharm.D., MBA, FNCS, FCCM, will present "PHARMacist avoidance or reductions in medical costs in CRITically ill adults rounding with one SERVICE compared to two or more services: PHARM-CRIT_SERVICE." Dave L. Dixon, Pharm.D., FCCP, will present "Role of lipoprotein(a) in atherosclerotic cardiovascular disease: A review of current and emerging therapies." Tyree H. Kiser, Pharm.D., FCCP, FCCM, BCCCP, BCPS, and Robert MacLaren, BSc, Pharm.D., MPH, FCCP, MCCM, will present "Management of noncytotoxic extravastatin injuries: A focused update on medications, treatment strategies and peripheral administration of vasopressors and hypertonic saline." We hope you will plan to join us to learn more about these exceptional papers.